Four Pharmacists Found Guilty In Remdesivir Scam

Kanpur : Four pharmacists have been found guilty in the Remdesivir scam at Lala Lajpat Rai (LLR) hospital, where injections were allegedly issued in the name of dead Covid-19 patients.

The committee headed by the chief development officer (CDO) has submitted the report to district magistrate (DM) Alok Tiwari. “The probe report has been received and four pharmacists have been found guilty. Action will be taken against them soon,” said the DM.

The doctors, meanwhile, have been given a clean chit in this case. Other employees have also been acquitted. These injections were issued from the store in the name of the two patients who had already died due to coronavirus.

During the second wave of Covid-19 pandemic, there was a crisis of Remdesivir injections in the market. People were ready to spend Rs 50,000 to Rs 55,000 for procuring the injection.

Taking advantage of this, black-marketeers started selling injections at premium rates.

Police had then arrested four persons including two nursing staff of LLR hospital for selling injections.

A few days later, it came to light that Remdesivir injections were issued against the names of the two Covid -19 patients admitted to the hospital, and who had already died. “Those injections were also shown to be administered to patients,” sources at LLR said.

The matter was brought to the knowledge of then principal of GSVM Medical college Prof. RB Kamal under whose jurisdiction the hospital comes.

On the basis of the report of the inquiry committee, he suspended the sister in-charge and pharmacist of the neuroscience centre of Covid-19 in the hospital and issued show-cause notices to eight nursing staff.

At the same time, the DM also ordered an inquiry. A three-member investigation team was formed under the supervision of CDO Mahendra Kumar, in which ADM (City) Atul Kumar and CMO were also included.

The committee has recommended action in the report considering four pharmacists guilty.

  • Related Posts

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Novo Nordisk submitted that a restraint order was required as Sun Pharma was ready to launch semaglutide tablets in the market the moment it would have marketing approval. And once…

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    MUMBAI: The Bombay High Court on Tuesday directed the Maharashtra Food and Drug Administration (FDA) to act “judiciously” after Cadila Pharmaceuticals Ltd challenged orders stopping the sale of some of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings